Align Technology, Inc. (ALGN)
NASDAQ: ALGN · Real-Time Price · USD
159.21
-5.08 (-3.09%)
At close: Mar 28, 2025, 4:00 PM
159.15
-0.06 (-0.04%)
After-hours: Mar 28, 2025, 7:54 PM EDT
Align Technology Market Cap
Align Technology has a market cap or net worth of $11.72 billion as of March 28, 2025. Its market cap has decreased by -49.78% in one year.
Market Cap
11.72B
Enterprise Value
10.79B
1-Year Change
-49.78%
Ranking
Category
Stock Price
$159.21
Market Cap Chart
Since January 30, 2001, Align Technology's market cap has increased from $769.80M to $11.72B, an increase of 1,422.15%. That is a compound annual growth rate of 11.92%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2025 | 12.09B | -22.32% |
Dec 31, 2024 | 15.57B | -25.83% |
Dec 29, 2023 | 20.99B | 27.39% |
Dec 30, 2022 | 16.47B | -68.21% |
Dec 31, 2021 | 51.82B | 22.98% |
Dec 31, 2020 | 42.14B | 91.60% |
Dec 31, 2019 | 21.99B | 31.29% |
Dec 31, 2018 | 16.75B | -5.97% |
Dec 29, 2017 | 17.81B | 132.55% |
Dec 30, 2016 | 7.66B | 46.35% |
Dec 31, 2015 | 5.23B | 16.61% |
Dec 31, 2014 | 4.49B | -2.19% |
Dec 31, 2013 | 4.59B | 103.21% |
Dec 31, 2012 | 2.26B | 21.17% |
Dec 30, 2011 | 1.86B | 25.00% |
Dec 31, 2010 | 1.49B | 12.37% |
Dec 31, 2009 | 1.33B | 126.20% |
Dec 31, 2008 | 586.60M | -48.68% |
Dec 31, 2007 | 1.14B | 27.70% |
Dec 29, 2006 | 895.10M | 122.94% |
Dec 30, 2005 | 401.50M | -38.40% |
Dec 31, 2004 | 651.80M | -32.58% |
Dec 31, 2003 | 966.80M | 628.01% |
Dec 31, 2002 | 132.80M | -38.40% |
Dec 31, 2001 | 215.60M | -71.99% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.71B |
UnitedHealth Group | 474.34B |
Johnson & Johnson | 395.32B |
AbbVie | 358.48B |
Novo Nordisk | 308.71B |
Abbott Laboratories | 228.08B |
Merck & Co. | 225.18B |
AstraZeneca | 225.00B |